Comparison of intravenous nicardipine and nitroglycerin to control systemic hypertension after coronary artery bypass grafting

The American Journal of Cardiology
R J VechtD G Gibson

Abstract

The efficacy of intravenous (i.v.) nicardipine hydrochloride (a calcium antagonist) compared with nitroglycerin, the drug generally used for treatment of hypertension after coronary artery bypass grafting, was tested in 20 postoperative patients. The patients were randomly divided in a nonblinded manner into 2 groups. Baseline characteristics were similar in the 2 groups. Patients in both groups received various oral calcium antagonists. In addition, 1 group was treated with i.v. nitroglycerin. Both drugs were infused at a maximal rate of 30 mg/hour, as needed to maintain systolic blood pressure below 110 mm Hg. If blood pressure increased to more than 120 mm Hg, nitroprusside was administered. Intravenous nicardipine was superior to nitroglycerin in control of hypertension after coronary artery bypass grafting. In patients treated with nicardipine, blood pressure was decreased sooner (mean infusion time 7.7 hours vs 11.9 hours for nitroglycerin), mean systolic blood pressure was reduced (94 vs 108 mm Hg for the nitroglycerin group; p less than 0.05), and no patient required nitroprusside treatment (compared with 3 patients who required this treatment in the nitroglycerin group). There were no differences in heart rate, diastol...Continue Reading

References

Oct 1, 1986·The American Journal of Cardiology·S ScheidtD Freedman
Jan 1, 1986·European Journal of Clinical Pharmacology·R A GreenbaumT R Evans

❮ Previous
Next ❯

Citations

Sep 1, 1995·Journal of Clinical Anesthesia·J D Tobias
Apr 5, 2003·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Shoji SuzukiIwao Yamaguchi
Jan 1, 1995·Paediatric Anaesthesia·J D TobiasJ K Deshpande
Mar 1, 1990·Journal of Clinical Pharmacology·G Chun, W H Frishman
Apr 29, 2000·Acta Anaesthesiologica Scandinavica·J Poelaert, C Roosens
May 9, 2019·Pediatric Cardiology·Caren J LiviskieChristopher C McPherson
Feb 11, 2000·The Annals of Pharmacotherapy·B L Erstad, J F Barletta

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.